We are an international group of biotechnology companies with expertise in immunodiagnostics, molecular diagnostics, and radio-immunodiagnostics. Founded in 1992 in the Czech Republic, we have grown from a local company into a global innovator with in-house research, development, and production of in-vitro diagnostic (IVD) products, supported by an international distribution network.
Our portfolio is structured around two complementary diagnostic pillars:
Immunodiagnostics
We provide a broad immunodiagnostic portfolio covering routine and specialized laboratory testing across key technologies.
CLIA
Markers in autoimmunity, diabetes, gastrointestinal diseases and Infectious serology, available exclusively on the KleeYa ® platform, expanding testing possibilities
MBA
Precision multiplex diagnostics for comprehensive antibody detection in autoimmune and infectious diseases.
BLOT
Reliable, robust technology for precise detection of specific antibodies.
ELISA
Complete portfolio for Infectious serology, immunology & endocrinology.
RIA/IRMA
Proved radioimmunoassays for endocrinology including unique niche parameters.
Antibodies
The foundation of immunoassays, driving performance across every diagnostic technology.
Molecular Diagnostics
In molecular diagnostics, BioVendor Group delivers solutions ranging from PCR-based assays to high-precision next-generation sequencing (NGS).
RealFast™️ Assay
IVDR certified real-time PCR assays for rapid detection of clinically relevant genetic variants and CNVs, covering CVD and pharmacogenetics.
StripAssay®
IVDR certified multiplex PCR and hybridization-based assays for simultaneous detection of clinically relevant genetic variants, covering Thalassemia and Cystic Fibrosis.
NGS Assay
Targeted sequencing for oncology, hereditary diseases, and microbiome analysis with integrated bioinformatics.
fastGEN™
One-step PCR NGS library preparation for challenging oncology samples, including
bioinformatic analysis.
BioVendor LM, BioVendor R&D, TestLine, ViennaLab, DiaSource, BioVendor MDx
Email: info@biovendor.group
www.biovendor.group
","pdfs":[{"id":"paper=cJSJJTlsRS64mdo62HfU9w","type":"paper","title":"BioVendor brochure 2026","source":"https://www.medica.de/vis-content/event-medica2026/exh-medica2026.3074450/MEDICA-2026-BioVendor-Laboratorni-medicina-a.s.-Paper-medica2026.3074450-MPpe6QGTSwmZZScu8RccWA.pdf","parentType":"profile","fileName":"BG-brochure-2026-08-EN (1).pdf","order":1,"visibleInLang":["en","de"]}],"tol":[],"categories":[{"id":"prod=medica2026.01.02.01","label":"Clinical chemistry & immunoassays","catalogIndex":"01.02.01","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=StUHt7YoSvSj8xL5Lq31jw","label":"Fully automated CLIA solution from BioVendor Group"},{"id":"prodinfo=HuiqKgnqRwu9CQ2mpnZXIg","label":"Microblot-Array (MBA) Technology from BioVendor: Multiplex Diagnostics with Precision, Efficiency, and Innovation"},{"id":"prodinfo=z12ovCcCSLSxCy33Al0NWA","label":"Precise Adrenal Function Assessment with Human CBG ELISA from BioVendor"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.01","label":"Clinical chemistry & immunoassays"}]},{"id":"prod=medica2026.01.02.02.01","label":"PCR & qPCR","catalogIndex":"01.02.02.01","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=4VWPT0fIRhCqRGhZltHWxw","label":"BioVendor Showcases Expanding Molecular Diagnostics Portfolio"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.02","label":"Molecular diagnostics & genomics"},{"id":"01.02.02.01","label":"PCR & qPCR"}]},{"id":"prod=medica2026.01.02.02.02","label":"Next-generation sequencing (NGS)","catalogIndex":"01.02.02.02","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=4VWPT0fIRhCqRGhZltHWxw","label":"BioVendor Showcases Expanding Molecular Diagnostics Portfolio"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.02","label":"Molecular diagnostics & genomics"},{"id":"01.02.02.02","label":"Next-generation sequencing (NGS)"}]},{"id":"prod=medica2026.01.02.03","label":"Microbiology & infectious disease diagnostics","catalogIndex":"01.02.03","eventIcons":[{"key":"medica2026","small":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-SzHinHZFRDix2fwVNyP4ag.png","tiny":"https://www.medica.de/vis-content/event-medica2026/all-exh/Event-0mOSbpheSRej6t2ZLcI1AA.png","label":"MEDICA 2026"}],"productList":[{"id":"prodinfo=StUHt7YoSvSj8xL5Lq31jw","label":"Fully automated CLIA solution from BioVendor Group"},{"id":"prodinfo=HuiqKgnqRwu9CQ2mpnZXIg","label":"Microblot-Array (MBA) Technology from BioVendor: Multiplex Diagnostics with Precision, Efficiency, and Innovation"}],"hierarchy":[{"id":"01","label":"Clinical Diagnostics & Therapeutic Technologies"},{"id":"01.02","label":"Laboratory, IVD & Diagnostics"},{"id":"01.02.03","label":"Microbiology & infectious disease diagnostics"}]}],"write":false,"lastModified":"2026-11-03T23:06:46Z","tagsAreEditable":false,"xtagsAreEditable":false,"isGetInTouchAllowed":false}